3006.30.10.00/Influenza Antigen Challenge Kit/Canada

Influenza Antigen Challenge Kit from Canada

Live attenuated influenza antigens for nasal challenge in immunity diagnostic studies. Classified in HTS 3006.30.10.00 as diagnostic reagents containing viral antigens administered directly to patients. Used in clinical trials for vaccine efficacy testing.

Duty Rate — Canada → United States

0%

Rate breakdown

9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Calculate with your customs valueVerify classification with AI

Import Tips

• Select agent registration if H5N1 strains; FDA IND for trial use

• BSL-2 lab certification for handling; include challenge protocol

• Label clearly for 'clinical trial diagnostic use' to stay in 3006

Influenza Antigen Challenge Kit from Canada — Import Duty Rate | HTS 3006.30.10.00